Sema4 Partners with Connecticut to Launch High-Capacity Covid-19 Testing
Sema4 is processing samples in its clinical laboratory, which can analyze 6,000 covid-19 tests per week and return results within 24 to 48 hours.
Read MoreSearch Results for: liver disease
Managing Prior Authorizations with Artificial Intelligence
AI-driven software can help labs expertly navigate the prior authorization landscape.
Read More
OxGene and Native Antigen Company Collaborate to Increase Covid-19 Antigen Production
The shared goal is to deliver high-purity, recombinant proteins for the development of covid-19 diagnostics and vaccines.
Read More
Urine Test Could Offer Early Detection of Lung Tumors
A noninvasive urine test that can detect the presence of proteins linked to lung cancer could help detect more tumors in the early stages of the disease.
Read MoreMacromoltek’s Computational De Novo Antibody Design to Target Covid-19
Computational (in silico) design allows for rapid iteration around potential solutions without the unique variables that traditional in vivo subjects may possess.
Read More